Practice
Featured experience
InSilico Medicine HK$2.62 billion IPO
We advised InSilico Medicine on its IPO and HKEX listing
Mastercard $1.8 billion acquisition of BVNK
We are advising Mastercard on the transaction
Sycamore Partners up to $23.7 billion acquisition of Walgreens Boots Alliance
We are advising Sycamore Partners on the transaction
Comcast spinoff of select cable television networks
We are advising Comcast on the transaction
Synchrony Financial $750 million subordinated notes offering
The investment-grade notes are due 2033
Heritage Power chapter 11 filing
We are advising GenOn and SVP in connection with the restructuring of Heritage Power
TD SYNNEX $502 million secondary offering
The shares are listed on the NYSE
TP Global Operations acquisition of Truphone’s non-Russian business and assets
We advised the acquirer of Truphone’s assets in a pre-packaged English administration
Pacific Biosciences $201.25 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
Precigen $75 million follow-on offering
We advised Precigen on the SEC-registered offering
Israel Discount Bank $800 million senior notes
We advised Israel Discount Bank on its debut Rule 144A / Regulation S senior notes offering
Deciphera Pharmaceuticals $135.1 million common stock offering
The common stock is listed on the Nasdaq Global Select Market
SGH private exchange offers
The company issued convertible senior notes due 2029
Bank of America $3 billion fixed-to-floating-rate notes
During the floating-rate period, the notes bear interest by reference to SOFR